| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Director | Common Stock | 133K | $270K | $2.03 | Jun 18, 2024 | Direct |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Director | Stock Option (right to buy) | 32.2K | Jun 18, 2024 | Direct | ||
| 4D Molecular Therapeutics, Inc. | Director | Stock Option (Right To Buy) | 26.8K | May 21, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Jun 18, 2024 | 2 | $0 | 4 | Jun 20, 2024 | Director |
| FDMT | 4D Molecular Therapeutics, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | May 24, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| FDMT | 4D Molecular Therapeutics, Inc. | May 23, 2023 | 1 | $0 | 4 | May 25, 2023 | Director |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| FDMT | 4D Molecular Therapeutics, Inc. | May 23, 2022 | 1 | $0 | 4 | May 25, 2022 | Director |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
| FDMT | 4D Molecular Therapeutics Inc. | May 17, 2021 | 2 | $0 | 4 | May 19, 2021 | Director |